| Clinical stage (FIGO) | Number of patients | Percentage |
| IB1 | 7 | 27 |
| IB2 | 13 | 50 |
| IIA2 | 1 | 4 |
| IIB | 5 | 19 |
| Age (years) | ||
| 20 - 39 | 9 | 35 |
| 40 - 49 | 4 | 15 |
| 50 - 59 | 7 | 27 |
| 60 - 69 | 6 | 23 |
| Histological subtype | ||
| Adenocarcinoma | 23 | 88 |
| Adenosquamous carcinoma | 3 | 12 |
| Adjuvant therapy | ||
| Concurrent chemoradiotherapy | 9 | 35 |
| Cisplatin | 5 | |
| Paclitaxel + Cisplatin | 4 | |
| Radiotherapy alone | 3 | 11 |
| Chemotherapy alone | 14 | 54 |
| Docetaxel + Carboplatin | 13 | |
| Paclitaxel + Cisplatin | 1 |